Corebridge Financial Inc. Purchases 5,002 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Corebridge Financial Inc. raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 26.1% in the 4th quarter, Holdings Channel reports. The firm owned 24,139 shares of the biotechnology company’s stock after acquiring an additional 5,002 shares during the period. Corebridge Financial Inc.’s holdings in Axon Enterprise were worth $14,346,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AXON. Groupama Asset Managment bought a new stake in shares of Axon Enterprise during the 3rd quarter worth $200,000. Vanguard Group Inc. lifted its holdings in shares of Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after acquiring an additional 275,959 shares during the last quarter. Proficio Capital Partners LLC bought a new stake in shares of Axon Enterprise during the 4th quarter valued at approximately $78,414,000. Assenagon Asset Management S.A. increased its position in Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after purchasing an additional 111,405 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Axon Enterprise in the fourth quarter valued at approximately $41,025,000. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on AXON. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. Barclays reissued a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Needham & Company LLC reaffirmed a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Stock Up 0.8 %

Shares of Axon Enterprise stock opened at $577.18 on Wednesday. The firm has a market cap of $44.23 billion, a price-to-earnings ratio of 149.14, a PEG ratio of 5.17 and a beta of 1.12. The stock’s 50-day moving average is $591.92 and its 200 day moving average is $546.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99.

Insiders Place Their Bets

In related news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.